Cargando…

Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models

Detalles Bibliográficos
Autores principales: Bao, Xingfeng, Albu, Diana, Huang, Kuan-Chun, Wu, Jiayi, Twine, Natalie, Nomoto, Kenichi, Woodall-Jappe, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649389/
http://dx.doi.org/10.1186/2051-1426-3-S2-P350
_version_ 1782401347885203456
author Bao, Xingfeng
Albu, Diana
Huang, Kuan-Chun
Wu, Jiayi
Twine, Natalie
Nomoto, Kenichi
Woodall-Jappe, Mary
author_facet Bao, Xingfeng
Albu, Diana
Huang, Kuan-Chun
Wu, Jiayi
Twine, Natalie
Nomoto, Kenichi
Woodall-Jappe, Mary
author_sort Bao, Xingfeng
collection PubMed
description
format Online
Article
Text
id pubmed-4649389
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493892015-11-24 Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models Bao, Xingfeng Albu, Diana Huang, Kuan-Chun Wu, Jiayi Twine, Natalie Nomoto, Kenichi Woodall-Jappe, Mary J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649389/ http://dx.doi.org/10.1186/2051-1426-3-S2-P350 Text en Copyright © 2015 Bao et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Bao, Xingfeng
Albu, Diana
Huang, Kuan-Chun
Wu, Jiayi
Twine, Natalie
Nomoto, Kenichi
Woodall-Jappe, Mary
Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title_full Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title_fullStr Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title_full_unstemmed Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title_short Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
title_sort combination of ep4 antagonist and checkpoint inhibitors promotes anti-tumor effector t cells in preclinical tumor models
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649389/
http://dx.doi.org/10.1186/2051-1426-3-S2-P350
work_keys_str_mv AT baoxingfeng combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT albudiana combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT huangkuanchun combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT wujiayi combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT twinenatalie combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT nomotokenichi combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels
AT woodalljappemary combinationofep4antagonistandcheckpointinhibitorspromotesantitumoreffectortcellsinpreclinicaltumormodels